On June 10, 2025, Corcept Therapeutics held its annual meeting where stockholders elected nine directors, ratified Ernst & Young as auditors for 2025, and approved executive compensation, with 92,327,139 shares voting out of 106,044,683 eligible shar
AI Assistant
CORCEPT THERAPEUTICS INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.